# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-22-082217
Filing Date
2022-12-22
Accepted
2022-12-22 16:30:52
Documents
61
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | f10k2022_citiuspharma.htm iXBRL | 10-K | 1082473
2 | DESCRIPTION OF COMMON STOCK | f10k2022ex4-25_citiuspharma.htm | EX-4.25 | 4470
3 | CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | f10k2022ex23-1_citiuspharma.htm | EX-23.1 | 1857
4 | CERTIFICATION | f10k2022ex31-1_citiuspharma.htm | EX-31.1 | 10751
5 | CERTIFICATION | f10k2022ex31-2_citiuspharma.htm | EX-31.2 | 10653
6 | CERTIFICATION | f10k2022ex32-1_citiuspharma.htm | EX-32.1 | 5303
| Complete submission text file | 0001213900-22-082217.txt |  | 4586451

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL SCHEMA FILE | ctxr-20220930.xsd | EX-101.SCH | 59617
8 | XBRL CALCULATION FILE | ctxr-20220930_cal.xml | EX-101.CAL | 35418
9 | XBRL DEFINITION FILE | ctxr-20220930_def.xml | EX-101.DEF | 207903
10 | XBRL LABEL FILE | ctxr-20220930_lab.xml | EX-101.LAB | 457455
11 | XBRL PRESENTATION FILE | ctxr-20220930_pre.xml | EX-101.PRE | 221659
55 | EXTRACTED XBRL INSTANCE DOCUMENT | f10k2022_citiuspharma_htm.xml | XML | 354660

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-38174 | Film No.: 221482317
SIC: 2834 Pharmaceutical Preparations